Immuneering Corporation
Immuneering Corporation's email is info@immuneering.com
and
Immuneering Corporation's phone number is (617) 500-8080
.
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. Immuneering has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses. Building on this experience, Immuneering has developed a disease-agnostic platform that enables the company to utilize hum...
read more
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. Immuneering has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses. Building on this experience, Immuneering has developed a disease-agnostic platform that enables the company to utilize human data, novel biology and chemistry, and translational planning to create and advance its wholly owned pipeline. Immuneering’s current development programs in oncology are focused on providing potential treatments for patients with solid tumors caused by mutations of oncologic signaling pathways, including the MAPK pathway. Immuneering’s lead product candidate, IMM-1-104, is designed to be a highly selective dual-MEK inhibitor that further disrupts KSR for the treatment of advanced solid tumors in patients harboring RAS mutant tumors. Additionally, Immuneering has six other oncology programs in the discovery stage that are designed to target either the MAPK or mTOR pathway, and two neuroscience programs in the discovery stage.
show less
Website | immuneering.com | |
Industry | Biotechnology | |
Location | Cambridge, Massachusetts, United States | |
Employees | 30 | |
Founded | 2008 |
HQ | 245 Main St, Second Floor | |
Phone | (617) 500-8080 | |
info@immuneering.com | ||
Funding | 57,199,807 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | immuneering.com | |
Industry | Biotechnology | |
Location | Cambridge, Massachusetts, United States | |
Employees | 30 | |
Founded | 2008 | |
linkedin.com/company/immuneering-corporation | ||
HQ | 245 Main St, Second Floor | |
Phone | (617) 500-8080 | |
info@immuneering.com | ||
Funding | 57,199,807 USD |
Email Patterns for Immuneering Corporation
Top Competitors for Immuneering Corporation
Immuneering Corporation Questions
Where are Immuneering Corporation's headquarters?
Immuneering Corporation's headquarters are in 245 Main St, Second Floor
What is Immuneering Corporation's phone number?
Immuneering Corporation's phone number is (617) 500-8080
What is Immuneering Corporation's official website?
Immuneering Corporation's website is immuneering.com
How many employees are working in Immuneering Corporation right now?
Immuneering Corporation has
30 employees.
View the Email and Phone Numbers for all 30 working at Immuneering Corporation.
What is Immuneering Corporation's industry?
Immuneering Corporation's industry is
Biotechnology
Who are Immuneering Corporation's top competitors?
Immuneering Corporation's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Immuneering Corporation's email address?
Immuneering Corporation's email address is info@immuneering.com
What are Immuneering Corporation's categories?
Immuneering Corporation's categories are Biotechnology, Medical, Pharmaceutical
What is Immuneering Corporation's location?
Immuneering Corporation's location is
Cambridge, Massachusetts, United States
When was Immuneering Corporation's founded?
Immuneering Corporation's founding year is 2008
What is Immuneering Corporation's funding?
Immuneering Corporation's funding is 57,199,807 USD
What is Immuneering Corporation's current status?
Immuneering Corporation's current status is ipo
Top Immuneering Corporation Employees
Senior Manager, Accounting And Operations
pfreire@gmail.com
+1908-868-4431
Vice President, Head Of Bioinformatics
alysaght@immuneering.com
+1617-500-8080
Vice President Clinical Operations
+1832-493-8110
Director, Bioinformatics
jb2@bu.edu
+1617-353-2300
Vice President, Head Of Business Development And Corporate Affairs
becky.kusko@gmail.com
+1617-500-8080
General Counsel And Secretary
michael.bookman@lw.com
+1212-906-1218
Executive Administrative Assistant
mmartin@immuneering.com
+1617-500-8080